Experian Finds 25 Percent Increase in Online Activity Since Covid-19
The pandemic-accelerated increase in digital transactions is here to stay and businesses must continue to transform their operations as they head into 2022. According to Experian’s latest Global Insights Report, there has been a 25 percent increase in online activity since Covid-19 and that number continues to hold steady.
“For the past 12 months, we've monitored the significant and sustainable shift toward ecommerce and digital financial services,” said Steve Wagner, global managing director of Decision Analytics for Experian. “The increase in digital activity has remained persistent, and consumers are staying online even with the return of physical shopping and banking.”
The study also found that as people begin to spend again consumer loyalty to online businesses is weakening. 61 percent of consumers say they are staying with the same online service provider they used prior to the pandemic. This a decrease of 6 percent from one year ago.
“Dwindling customer loyalty along with heighted customer expectations and increased competition could mean potential revenue loss or gain. Business must find solutions to improve digital engagement and customer acquisition,” added Wagner.
Companies are leveraging advanced technologies to improve the digital customer experience and grow their business including digital credit risk decisioning, passive authentication, artificial intelligence and more. According to our research, 90 percent of companies are investing in business automation, 76 percent are improving or rebuilding their analytics models and 65 percent intend to increase fraud budgets.
To develop the study, Experian interviewed 3,000 consumers and 900 businesses across 10 countries around the world including Australia, Brazil, Germany, India, Italy, Japan, Singapore, Spain, United Kingdom and United States on insights related to consumer and business economic outlooks, financial well-being, online behavior and more. This report is the fourth wave in a longitudinal study exploring the major shifts in consumer behavior and business strategy throughout Covid-19.
Additional findings from the report include:
- Nearly 10 percent of consumers are spending more and putting less away in retirement or emergency savings than a year ago
- Half of consumers (49%) conducted personal banking and payment activities online regularly
- Adoption of AI has risen from 69% to 74% and machine learning from 68% to 73% in one year
- 50 percent of companies are exploring the use of expanded data sources
Download the latest Global Insights Report to learn about more findings from Experian Decision Analytics.
About Experian
Experian is the world’s leading global information services company. During life’s big moments — from buying a home or a car to sending a child to college to growing a business by connecting with new customers — we empower consumers and our clients to manage their data with confidence. We help individuals to take financial control and access financial services, businesses to make smarter decisions and thrive, lenders to lend more responsibly, and organizations to prevent identity fraud and crime.
We have 17,800 people operating across 44 countries, and every day we’re investing in new technologies, talented people and innovation to help all our clients maximize every opportunity. We are listed on the London Stock Exchange (EXPN) and are a constituent of the FTSE 100 Index.
Learn more at or visit our global content hub at our global news blog for the latest news and insights from the Group.
Experian and the Experian marks used herein are trademarks or registered trademarks of Experian and its affiliates. Other product and company names mentioned herein are the property of their respective owners.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20211109005351/en/
Contact information
Kristie Galvani
Rubenstein Public Relations
1 212 805 3005
kgalvani@rubensteinpr.com
Scott Anderson
Experian Public Relations
1 714 830 3185
scott.n.anderson@experian.com
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Life-saving Technologies at EuroELSO 2025: Eurosets Presents Landing Breathe and Xtreme Rescue28.4.2025 13:16:00 CEST | Press Release
Eurosets, a cutting-edge Italian company specializing in the design of life-saving medical devices, unveils two crucial innovations at the EuroELSO 2025 congress: Landing Breathe and Xtreme Rescue. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250428669720/en/ Ettore Sansavini, GVM Care & Research President, and Antonio Petralia, CEO and Executive Vice President of Eurosets, with Xtreme Rescue and Jetson One Landing Breathe is a next-generation capnometer designed to provide comprehensive monitoring of both the mechanical oxygenator lung and the native lung during ECMO (extracorporeal membrane oxygenation) treatments. The device integrates with Landing Advance, which already analyzes 22 metabolic parameters. Thanks to this technology, clinicians can rely on a real-time, full picture of the patient’s respiratory condition, optimizing therapeutic management. Alongside this innovation, Eurosets also presents Xtreme Rescue, a p
Quantum Computing’s Rapid Rise Is a Risk to Cybersecurity and Business Stability – but Organisations Are Unprepared28.4.2025 13:00:00 CEST | Press Release
Quantum computing has revolutionary potential; expected to change life as we know it – and is broadly welcomed by 56% of cyber and IT professionals as creating opportunities for business. That’s according to new research from ISACA, the leading global professional association helping individuals and organisations in their pursuit of digital trust. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250428853346/en/ ISACA’s 2025 Quantum Computing Pulse Poll features of-the-moment insights from 2,685 global professionals who work in digital trust fields, including cybersecurity, audit, risk or data privacy. This includes 529 respondents from across Europe, providing a focused view on how European organizations perceive and prepare for the quantum future. However, the research revealed that despite a general sense of optimism about its revolutionary potential – as 44% believe quantum will create revolutionary innovations – IT profes
FPT Recognized in The Digital Transformation Services Landscape Report28.4.2025 12:06:00 CEST | Press Release
Global IT firm FPT announced its inclusion in Forrester’s The Digital Transformation Services Landscape, Q2 2025. The report provides an overview of 35 digital transformation service providers and offers valuable insights into the current market dynamics. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250428400623/en/ FPT is recognized as a Notable Provider in the report which stated that transformation leaders can use digital transformation services to “articulate and orchestrate strategy-aligned transformation journeys; align tech modernization with people, organization, and culture change, and navigate transformation risks.” The report notes FPT's geographical focus in North America and Asia-Pacific, along with its industry focus in financial services, IT/Tech services, and manufacturing/production of industrial products. FPT’s suite of digital transformation services includes cutting-edge solutions in AI, cloud computing
Vertex Receives CHMP Positive Opinion for ALYFTREK ® , a New Once-Daily CFTR Modulator for the Treatment of Cystic Fibrosis28.4.2025 08:03:00 CEST | Press Release
Vertex Pharmaceuticals (Nasdaq: VRTX) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion for ALYFTREK®(deutivacaftor/tezacaftor/vanzacaftor)for the treatment of people with cystic fibrosis (CF) ages 6 years and older who have at least one non-class I mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. “Our goal has always been to serially innovate to help people with cystic fibrosis live healthier and longer lives. If approved, this new medicine would be indicated for people with CF ages 6 years and older with at least one non-class I mutation, meaning more patients would be eligible for a medicine that gets them closer to normal levels of sweat chloride,” said Carmen Bozic, M.D., Executive Vice President, Global Medicines Development and Medical Affairs, and Chief Medical Officer, Vertex. “CFTR modulators have already revolutionized the way we treat CF and I am encoura
Prilenia Enters into a Collaboration and License Agreement with Ferrer for the Commercialization and Co-Development of Pridopidine in Europe and Other Select Markets28.4.2025 07:02:00 CEST | Press Release
Prilenia Therapeutics B.V., a biopharmaceutical company driven by an unwavering commitment to scientific excellence and accelerating progress for people affected by Huntington’s disease (HD) and amyotrophic lateral sclerosis (ALS), today announced that it has entered into a collaboration and license agreement with Ferrer for the commercialization and further development of pridopidine in Europe and other select markets. Pridopidine is a potent and highly selective, orally administered sigma-1 receptor (S1R) agonist designed to regulate key neuroprotective mechanisms often impaired in neurodegenerative diseases such as HD and ALS. Under the terms of the agreement, Prilenia will receive an upfront payment of approximately €80 million plus up to €45 million in near-term development, regulatory, and commercial milestones. The total deal is valued at up to approximately €500 million in upfront and total milestone payments. In addition, Prilenia will receive tiered double-digit royalties on
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom